Latest News
Dow Surges 615 Points, But Rally Relies on Just Two Stocks
The Dow closed up 615 points, but nearly all gains came from Microsoft and Goldman Sachs, highlighting a fragile rally.
Ambev ADRs Recover from Steep Drop as Cash Flow Surge Fuels Optimism
Ambev ADRs recovered sharply after a 5.5% intraday slide, as Q2 operating cash flow jumped 54.5%, though 79% of the rise came from working capital.
Transocean Shares Up 2.2% on Merger Arbitrage Opportunity as Valaris Deal Spread Widens
Transocean shares advanced 2.2% amid a widening merger spread with Valaris to 2.4%, as regulatory milestones and robust Q2 guidance bolster arbitrage expectations.
UiPath Stock Slides on Weak ARR Growth Forecast for Q2
UiPath stock dropped 3.3% after the company projected Q2 net new ARR between $28M and $33M, a 38% decline from Q1, signaling decelerating growth.
Ellison Family Faces $9.8B Risk in Warner Bros. Deal, Exceeding Paramount's Value
The Ellison family's potential $9.8 billion liability in the Warner Bros. takeover exceeds Paramount's $8.66 billion market cap, as WBD shares trade at a discount and regulatory risks loom.
Corcept Shares Leap 27% on Strong Lifyorli Launch and Upbeat Guidance
Corcept Therapeutics shares jumped 27.4% after Q2 revenue rose 32% to $256.1M, driven by Lifyorli sales of $47.6M. The company lifted its 2026 revenue outlook to $1.1-1.2 billion.
